Biopharma News
Biopharma news
-
News Dermira secures raises funding for dermatology innovation
The company is aiming develop and commercialise innovative new therapies in dermatology. -
News Heroin vaccine proves successful in animal trials
Researchers have developed a possible vaccine for heroin addiction -
News Better and more effective drugs 'on their way'
Scientists are learning more about how drugs work , which could lead to better, more effective versions. -
News Evidence confirms EPA and skin graft failure are linked
Research has suggested EPA is associated with skin graft failure -
News Scientists make breakthrough on which patients may face dengue virus complications
Researchers have made a breakthrough on why some dengue virus patients develop complications -
News Study identifies potential targets for pharmacological efforts to tackle obesity
Potential targets have been identified for pharmacological efforts to address obesity -
News Promising pre-clinical data on TG1050 presented at EASL 2013
Pre-clinical data on TG1050 was presented at EASL 2013, which took place in Amsterdam -
News Chemoresponse assays may improve ovarian cancer survival rates
A study has shown chemoresponse assays could be effective for improving ovarian cancer survival rates. -
News New melanoma treatment given Breakout Therapy status by FDA
Merck is celebrating after its new melanoma treatment was given Breakout Therapy status by the FDA -
News Microwave tomography helps identify effectiveness of breast cancer treatment
Microwave imaging may be a useful way to monitor the effectiveness of breast cancer treatment. -
News FDA grants orphan drug designation for drug to treat pain of erythromelalgia
A pain treatment is one step closer to targeting the rare disease erythromelalgia. -
News CE Mark awarded to anti-CCP diagnostic kit
A diagnostic kit for rheumatoid arthritis has been given a CE Mark. -
News Plans afoot to grow complex 3D human tumour microenvironment in the lab
A project is in the pipeline to grow a complex 3D tumour microenvironment in vitro. -
News First implantation of resorbable antibacterial envelope announced
The debut implantation of a resorbable antibacterial envelope has been revealed. -
News Individual genes impact on effectiveness of smallpox vaccination
Research finds effectiveness of smallpox vaccine is down to genes. -
News Researchers a step closer to anti-obesity drug
A team of scientists are closer to developing an anti-obesity drug -
News Median Technologies awarded phase II clinical trial on NSLC
Median Technologies has been awarded a phase II clinical trial on non-small lung cancer -
News Radiation dose impacts on size of lung nodules seen on CT images
Research has shown how radiation dose can affect size of lung nodules observed on CT images. -
News 61% of doctors agree branded drug therapies could reduce cost of patient care, survey finds
A survey has shed light on some physcicians' attitudes to pharmaceutical companies. -
News FDA review periods extending for IVD tests
A report has suggested FDA review periods for biomarker-based IVD tests are getting longer. -
News Technology in the pipeline to measure the potential success of radiation therapy
Technology is being developed to predict the effectiveness of radiation therapy. -
News Minocycline improves mood of children with FXS
An antibiotic drug has been found to be beneficial for children with fragile X. -
News Hammersmith gets local connection rule
London local authority restricts social housing. -
News Exercise brings cognitive benefits, trial shows
Clinical trial proves link between mental and physical exercise and better cognitive function. -
News SK Biopharmaceuticals announces strategic alliance for drug development
A South Korean firm is working with Chinese CROs to develop its new drug formulation for treatment of depression. -
News Nottingham supporting European drug discovery drive
The University of Nottingham is involved in the European Lead Factory drug discovery drive. -
News New monoclonal antibody developed that can target proteins inside cancer cells
Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cel... -
News Enrollment completed for next phase of lung cancer clinical trial
Enrollment has been completed for a Phase 2b clinical trial of a lung cancer drug candidate. -
News AMSilk Develops Worlds First Man-Made, Scalable Spider Silk Fiber
The worlds first competitive man-made spider silk fiber, called Biosteel has mechanical properties similar to that of natural spider silk. -
News Activartis Receives Orphan Drug Designation for its Cancer Immune Therapy AV0113
The European Medicines Agency recently awarded the Austrian biotech company Activartis an Orphan Drug Designation for its innovative Cancer Immune Therapy AV0113 -
News Drug formulation devices to boost biologics market
Combining drug formulations with a device for delivery will make self-administration easier for patients. -
News Data from clinical trials waits almost two years for publication
A study finds US clinical trials are not revealed in peer-reviewed journals for around 21 months. -
News First European Laboratory Obtains Accreditation for New Tissue-Typing Method for Stem Cell Transplants
Tests based on next-generation sequencing with Roches GS Junior System -
News Almac, DSM Advance Biocatalysis Pact
A collaboration between Almac and DSM Pharmaceutical Products has successfully transferred enzymes for enzyme screening, process development and scale-up manufacture. -
News Patent received for new drug delivery system tech
A new drug delivery system has been developed by BioChemics that involves creating targeted molecules. -
News Additional testing completed on Alzheimer's disease biomarker
Navidea has announced completion of tests into the impact of mass doses of its NAV4694 biomarker on PET scans of patients with Alzheimer's. -
News Skin substitute trials 'a success'
Patients will no longer have to undergo painful autografting for second-degree burns. -
News Additional testing completed on Alzheimer's disease biomarker
avidea has announced completion of tests into the impact of mass doses of its NAV4694 biomarker on PET scans of patients with Alzheimer's. -
News NGM, Janssen in Diabetes Discovery Alliance
NGM Biopharmaceuticals has signed a worldwide agreement with Janssen Pharmaceuticals to discover and develop therapeutics for the potential treatment of Type 2 diabetes and other metabolic diseases. -
News Evotec Acquires Cell Culture Service
Evotec AG has acquired Cell Culture Service GmbH (CCS), based in Hamburg, Germany, for $1.5 million in cash and an earn-out payment of $1.4 million in cash. -
News Report explores trends and opportunities in life sciences
Frost & Sullivan has published its latest research on the global life sciences industry. -
News Sartorius Stedim Biotech Expands PAT Software Portolio for Optimization of Biopharmaceutical Development and Manufacturing Processes
Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, has entered into a global sales partnership with Umetrics AB, a Swedish software manufacturer. -
News Nuron Biotech acquires Meningitec vaccine from Pfizer
Nuron Biotech has expanded its vaccine portfolio with the acquisition of Meningitec from Pfizer -
News US biopharma developing 221 new diabetes medicines
Biopharmaceutical companies in the US are working on a range of treatments for type-1 and type-2 diabetes and related complications. -
News Selecta Biosciences and Sanofi to collaborate on allergy vaccines
Sanofi will use Selecta's proprietary synthetic vaccine particle technology to develop highly targeted immunotherapies against life-threatening allergens. -
News Biogen Idec opens new US facility
Biogen Idec has opened a new facility focusing on patient care in RTP, North Carolina. -
News BioCryst and Presidio call off proposed merger
BioCryst's proposed acquisition of Presidio Pharmaceuticals will no longer go ahead. -
News TOT Biopharm opens new production facility in China
TOT Biopharm has held an inauguration ceremony for its new factory complex in Suzhou, China. -
News Sanofi ranks third on the Access to Medicine Foundation's 2012 ATM Index
Sanofi ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM Index) . -
News Report reveals fall in biomarker approval volumes
Amplion Research's latest report looks at approval trends for biomarker-based IVD tests in the US. -
News Pharma giants shift focus towards biologics
Biopharmaceuticals and biologics in particular are coming into their own, according to the latest GBI Research report. -
News Bristol-Myers Squibb Foundation's Together on Diabetes marks World Diabetes Day
The Bristol-Myers Squibb Foundation has marked World Diabetes Day and the second anniversary of its Together on Diabetes initiative by issuing the initiative's second annual report and awarding two new grants to partners in India. -
News Sanofi and T1D Exchange to launch worldwide study
Sanofi (EURONEXT: SAN and NYSE: SNY) and T1D Exchange, a non-profit organization focused on type 1 diabetes, will collaborate on the TEENs registry study. -
News BioCat and ALPCO Diagnostics Sign Exclusive Distribution Agreement
BioCat, a distributor of research reagents and cutting-edge technologies in the fields of genomics, proteomics, and cell biology, announces the signing of an exclusive distribution agreement with ALPCO Diagnostics. -
News Incyte Wins $50M from Lilly as RA Drug Enters Phase III
Incyte won a $50 million milestone payment from Eli Lilly tied to formal initiation of the rheumatoid arthritis (RA) Phase III program for baricitinib, Incytes oral JAK1/JAK2 inhibitor (formerly INCB28050). -
News Jubilant HollisterStier Wins Parenteral Contracts
Jubilant HollisterStiers Contract Manufacturing & Services division, a subsidiary of Jubilant Life Sciences, has recently secured more than $100 million in contracts with pharmaceutical companies for the commercial manufacture of multiple sterile... -
News Catalent, Cevec in Cell Line Sales Pact
Catalent Pharma Solutions and Cevec Pharmaceuticals have entered a commercial cell line sales agreement for recombinant human alpha-1 antitrypsin (hAAT). -
News Boehringer Ingelheim enters strategic collaboration agreement to support Molecular Partner's proprietary pipeline
Boehringer Ingelheim's biopharmaceutical contract manufacturing business and Molecular Partners have entered into a strategic manufacturing collaboration. -
News Pharma firms choosing to run more phase-IV trials
The number of voluntarily initiated phase-IV clinical trials has increased in recent years, a study has found. -
News Impax Labs reports increasing incomes
Sales of Zomig drove income at Impax Laboratories during the third quarter of the year. -
News Sigma-Aldrich enters South Korean biopharma market
Sigma-Aldrich will provide its pre-formulation services to CrystalGenomics in Seoul. -
News Consistent long-term govt policies 'key' to biopharmaceutical innovation
A new report has highlighted key factors for the success of biopharmaceutical innovation. -
News Novartis to build new biotech centre in Singapore
Novartis is investing more than $500 million in a new facility in Tuas. -
News Patheon to acquire Banner Pharmacaps
Patheon is to acquire Banner Pharmacaps for US$255 million, the company has confirmed. -
News Bluebird awarded funding for trials of LentiGlobin
A gene therapy developer has received funding for trials of its new treatment for beta-thalassmia. -
News Medicine prices 'under control' in the UK
The cost of medicine in the UK is among the lowest of all developed nations. -
News Biogen Idec sees 6% growth in Q3 2012
Biogen enjoyed strong results in the third quarter of 2012. -
News Ezose Sciences licences GlycanMap tech in efforts to discover MS biomarkers
GlycanMap will be used in the search of new biomarkers for MS. -
News Industry welcomes consultation on research exceptions
The BioIndustry Association has welcomed a consultation on proposals to clarify the legal framework within which researchers operate with regard to intellectual property. -
News Biopharma trials scheduled for oral antipsychotic BL-1020
BioLine has announced plans to conduct an interim analysis of current Phase II and III trials of BL-1020, its orally available GABA-enhanced antipsychotic for treatment of schizophrenia. The analysis will take place in the coming months, with a complet... -
News DSM and Paranta Biosciences sign biologics contract manufacturing agreement
DSM will manufacture recombinant human follistatin at its facility in Brisbane. -
News Pfizer to acquire ADHD specialist NextWave
Pfizer has announced its intention to exercise its option to acquire NextWave Pharmaceuticals. -
News Confidential pricing agreements reduce impact of low drug prices
A study by Cutting Edge Information has revealed the importance of confidential pricing agreements when launching a new product. -
News Pharmaceutical companies place greater emphasis on patient adherence
There has been a noticeable shift towards ensuring patients get the most out of their medication. -
News Dedicated budgets for medical publication teams 'linked to higher output'
Setting aside a dedicated budget for medical publication tends to be associated with a higher output of manuscripts and abstracts, a report has shown. -
News New excipients on show at CPhl Worldwide in Madrid
New excipients will be on show at a pharmaceuticals event in Madrid later this month. -
News BioSante Pharmaceuticals and ANI Pharmaceuticals announce merger
BioSante and ANI have announced a merger agreement and will form a new combined company. -
News Rapid uptake of biosimilars expected in US
Adoption of biosimilars is expected to be rapid in the US - at least in the field of nephrology. -
News Takeda to acquire vaccine specialist LigoCyte
Takeda is to acquire LigoCyte Pharmaceuticals and its norovirus vaccine candidate. -
News Big pharma collaborate to speed up drug development
TransCelerate BioPharma is a non-profit organisation set up by ten biopharmaceutical giants. -
News China emerging as 'major player' for pharmaceuticals
China wants to become a major developer of vaccines for the developing world. -
News Eutropics wins NCI contract
Eutropics will provide its BH3 profiling diagnostic assay to the NCI. -
News BioLineRx publishes results of BL-1020 Phase II testing
BioLineRx has reported positive results from Phase II testing of its new schizophrenia treatment BL-1020. -
News Colorcon offers customers to expertise in film coating formulation processes
Colorcon will provide customers with access to expertise on film coating formulation processes for Quality by Design (QbD) requirements. -
News BioTime forms new acquisitions arm
BioTime has established a new subsidiary to oversee its strategic acquisitions. -
News Novo Nordisk investing in China's biopharma supply chain
Novo Nordisk is investing in the Chinese biopharmaceuticals supply chain with the establishment of a new research and development centre. -
News Watson Pharma sues FDA over generic Actos ruling
Watson Pharmaceuticals believes it is entitled to shared marketing exclusivity on generic Actos. -
News Capacity Issues and the Question: To Insource or Outsource?
Whether to insource or outsource the production of sterile injectable drugs is influenced by capacity. -
News Scottish Biotech Aquapharm Discovers Novel Antibiotic Compound
Aquapharm Biodiscovery believes the marine-derived compound AQP-182 could help to tackle multi-drug resistant bacteria. -
News Biotechs Face Squeeze on Partnering Deals
Biotechs are finding it increasingly difficult to secure partnering deals with pharmaceutical companies. -
News CEVEC Licenses Proprietary Human Cell Lines to Paragon Bioservices
Paragon Bioservices would license and use CEVEC's know-how and patents to develop stable cell lines and perform process development for the contract manufacturing of recombinant proteins and antibodies. -
News Parexel BioPharm Unit to Serve Small and Mid-sized Biopharma
Parexel's new dedicated unit will meet the needs of small biopharmaceutical companies. -
News iBio & GE Healthcare Announce New Global Alliance
iBio and GE Healthcare are working together to develop a single facility for the manufacturing of plant-based biotherapeutics and vaccines. -
News Report Reveals Fall in Venture Capital Investment in US Biotech And Pharma Start-ups
There has been a fall in venture capital investment in the life sciences industry in the US. -
News US Biopharmaceuticals Have Almost 200 Mental Illness Drugs in Development
There are almost 200 biopharmaceutical products for mental illness in development in the US at this time. -
News Compugen & Merck Serono Establish Novel Biomarker Company
Neviah Genomics is a new company being created by Compugen and Merck Serono. -
News Biopharmaceutical Companies Face Document Management Challenges
A survey has highlighted the challenges faced by life sciences companies with regard to document management. -
News Debiopharm & Ascepion to Collaborate on New Oncology Drug
Swiss-based Debiopharm Group and China's Ascepion Pharmaceuticals hope to bring a new anti-cancer drug to market. -
News DSM Announces Patent Grants for Proprietary XD Biomanufacturing Technology
DSM Pharmaceutical Products has announced that several countries have granted patents or have given statements of patent allowance to its proprietary XD? high cell density process technology. -
News BioInvent & Cancer Research Technology Announce Oncology Collaboration
A new collaboration between BioInvent, Cancer Research Technology and Queen Mary, University of London will aim to speed up the discovery and development of new cancer treatments. -
News Biopharma Must Understand Local Healthcare Needs, Report Says
Biopharmaceutical services company Quintiles has highlighted the need for drugmakers to adapt their marketing strategies. -
News New Stemcell Technologies Products to Advance Pluripotent Stem Cell Research
Stemcell Technologies is adding a series of new products to its portfolio of high quality cell culture media for stem cell scientists. -
News BioCryst Pharmaceuticals announces restructuring
BioCryst is streamlining its portfolio of antivirals in a bid to lower costs.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance